Lihuayi Group

Lihuayi Group is a large, multi-industry Chinese conglomerate headquartered in Dongying, Shandong, that maintains a strong and specialized presence in the life sciences sector. Its pharmaceutical activities are primarily conducted through its subsidiary, Shandong Phoenix Pharmaceutical, which is a recognized National Modern Traditional Chinese Medicine (TCM) Industrialization Base. The company focuses on integrating traditional herbal wisdom with modern pharmacology, specializing in cardiovascular, cerebrovascular, and metabolic health. Flagship products include the Tiandan Tongluo Capsule, used for stroke recovery, and the Compound Chuanxiong Capsule for treating coronary heart disease. Additionally, Lihuayi produces synthetic small molecule drugs for diabetes and HIV treatment. The group leverages its extensive manufacturing infrastructure to maintain a vertically integrated supply chain, from chemical raw materials to finished pharmaceutical products.